Hisamitsu Pharmaceutical Financials
| HPX Stock | EUR 24.80 0.40 1.59% |
Hisamitsu |
Understanding current and past Hisamitsu Pharmaceutical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Hisamitsu Pharmaceutical's financial statements are interrelated, with each one affecting the others. For example, an increase in Hisamitsu Pharmaceutical's assets may result in an increase in income on the income statement.
Hisamitsu Pharmaceutical Stock Summary
Hisamitsu Pharmaceutical competes with Merck, Takeda Pharmaceutical, HANSOH PHARMAC, Guangzhou Baiyunshan, and ASPEN PHARUNADR. Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. HISAMITSU PHARMA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2770 people.| Foreign Associate | USA |
| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | JP3784600003 |
| Business Address | 408, Tashiro Daikan-machi, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.hisamitsu.co.jp |
| Phone | 81 3 5293 1720 |
| Currency | EUR - Euro |
You should never invest in Hisamitsu Pharmaceutical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Hisamitsu Stock, because this is throwing your money away. Analyzing the key information contained in Hisamitsu Pharmaceutical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Hisamitsu Pharmaceutical Key Financial Ratios
There are many critical financial ratios that Hisamitsu Pharmaceutical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Hisamitsu Pharmaceutical reports annually and quarterly.| Return On Equity | 0.0504 | |||
| Return On Asset | 0.0212 | |||
| Beta | 0.51 | |||
| Z Score | 5.4 | |||
| Last Dividend Paid | 42.0 |
Hisamitsu Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hisamitsu Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Hisamitsu Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hisamitsu Pharmaceutical competition to find correlations between indicators driving Hisamitsu Pharmaceutical's intrinsic value. More Info.Hisamitsu Pharmaceutical Co is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.42 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Hisamitsu Pharmaceutical Co is roughly 2.38 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hisamitsu Pharmaceutical's earnings, one of the primary drivers of an investment's value.Hisamitsu Pharmaceutical Systematic Risk
Hisamitsu Pharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Hisamitsu Pharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Hisamitsu Pharmaceutical correlated with the market. If Beta is less than 0 Hisamitsu Pharmaceutical generally moves in the opposite direction as compared to the market. If Hisamitsu Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Hisamitsu Pharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Hisamitsu Pharmaceutical is generally in the same direction as the market. If Beta > 1 Hisamitsu Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark.
Hisamitsu Pharmaceutical December 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Hisamitsu Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Hisamitsu Pharmaceutical Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hisamitsu Pharmaceutical Co based on widely used predictive technical indicators. In general, we focus on analyzing Hisamitsu Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hisamitsu Pharmaceutical's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.21 | |||
| Information Ratio | 0.0126 | |||
| Maximum Drawdown | 19.7 | |||
| Value At Risk | (2.29) | |||
| Potential Upside | 1.68 |
Complementary Tools for Hisamitsu Stock analysis
When running Hisamitsu Pharmaceutical's price analysis, check to measure Hisamitsu Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hisamitsu Pharmaceutical is operating at the current time. Most of Hisamitsu Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Hisamitsu Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hisamitsu Pharmaceutical's price. Additionally, you may evaluate how the addition of Hisamitsu Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |